___

• Teng CC, Sze CI, Liao WC. Induction of apoptosis of malignant gliomas cells by a prenylated chalcone. Pharm Biol 2014; 52: 471-8.
• Dolecek TA, Propp JM, Stroup NE, Kruchko C. CBTRUS statistical report: primarybrain and central nervous sys- tem tumors diagnosed in the United States in 2005-2009. Neuro Oncol 2012; 14: 1-49.
• Laks DR, Visnyei K, Kornblum HI. Brain tumor stem cells as therapeutic targets in models of glioma. Yonsei Med J 2010; 51: 633-40.
• Bhattacharya D, Singh MK, Chaudhuri S, Acharya S, Basu AK, Chaudhuri S. T11TS impedes glioma angiogenesis by inhibiting VEGF signaling and pro- survival PI3K/Akt/eNOS pathway with concomitant upregulation of PTEN in brain endothelial cells, J Neurooncol 2013; 113: 13-25.
• Grant R, Kolb L, Moliterno J. Molecu- lar and genetic pathways in gliomas: the future of personalized therapeutics. CNS Oncol 2014; 3: 123-36.
• Sarin H. Recent progress towards development of effective systemic chemotherapy for the treatment of malignant brain tumors. J Transl Med 2009; 7: 77.
• Xiang Z, Ning Z. Scavenging and antioxidant properties of compound derived from chlorogenic acid in South-China honey suckle. Food Sci- and Technol 2008; 41:1189-203.
• Bubulica MV, Anghel I, Grumezescu AM, Saviuc C, Anghel GA, Chifiriuc MC, Gheorghe I, Lazar V, Popescu A. In vitro evaluation of bactericidal and antibiofilm activity of Lonicera tatari- ca and Viburnum opulus plant ex- tracts on staphylococcus strains. Far- macia 2012; 60: 80-91.
• Han J, Lv QY, Jin SY, Zhang TT, Jin SX, Li XY, Yuan HL. Comparison of anti-bacterial activity of three types of di-O-caffeoylquinic acids in Lonicera japonica flowers based on microcalo- rimetry. Chin J Nat Med 2014; 12: 108-13.
• Kim SJ, Yoon SJ, Kim YM, Hong SW, Yeon SH, Choe KI, Lee SM. HS- 23, Lonicera japonica extract, attenu- ates septic injury by suppressing toll- like receptor 4 signaling. J Eth- nopharmacol 2014; 155: 256-66.
• Sochor J, Jurikova T, Pohanka M, Skutkova H, Baron M, Tomaskova L, Balla S, Klejdus B, Pokluda R, Mlcek J, Trojakova Z, Saloun J. Evaluation of antioxidant activity, polyphenolic compounds, amino acids and mineral elements of representative genotypes of Lonicera edulis. Molecules 2014; 19: 6504-23.
• Erdem MG, Cinkilic N, Vatan O, Yilmaz D, Bagdas D, Bilaloglu R. Genotoxic and anti-genotoxic effects of vanillic acid against mitomycin C- induced genomic damage in human lymphocytes in vitro. Asian Pac J Cancer Prev 2012; 13: 4993-8.
• Soory M. Nutritional antioxidants and their applications in cardiometabolic diseases, Infect Disord Drug Target 2012; 12: 388-401.
• Weng CJ, Yen GC. Chemopreventive effects against cancer invasion and metastasis: phenolic acids, monophenol, polyphe- nol, and their derivatives. Cancer Treat Rev 2012; 38: 76-87.
• Habibi E, Shokrzadeh M, Chabra A, Naghshvar F, Keshavarz-Maleki R, Ahmadi A. Protective effects of Origa- num vulgare ethanol extract against cy- clophosphamide-induced liver toxicity in mice. Pharm Biol 2015; 53: 10-5.
• Husein AI, Ali-Shtayeh MS, Jondi WJ, Zatar NA, Abu-Reidah IM, Jamous RM. In vitro antioxidant and antitumor activities of six selected plants used in the Traditional Arabic Palestinian herb- al medicine. Pharm Biol 2014; 52: 1249-55.
• Flanigan PM, Niemeyer ED. Effect of cultivar on phenolic levels, anthocyanin composition, and antioxidant properties in purple basil (Ocimum basilicum L.). Food Chem 2014; 164: 518-26.
• Kolodziejczyk-Czepas J, Nowak P, Kowalska I, Stochmal A. Biological ac- tivity of clovers - Free radical scaveng- ing ability and antioxidant action of six Trifolium species. Pharm Biol 2011; 52: 1308-14.
• Taheri S, Abdullah TL, Karimi E, Os- koueian E, Ebrahimi M. Antioxidant Capacities and Total Phenolic Contents Enhancement with Acute Gamma Irra- diation in Curcuma alismatifolia (Zin- giberaceae) Leaves. Int J Mol Sci 2014; 15: 13077-90.
• Wahle KW, Brown I, Rotondo D, Heys SD. Plant phenolics in the prevention and treatment of cancer. Adv Exp Med Biol 2010; 698: 36-51.
• Mahassni SH, Al-Reemi RM. Cytotoxic effect of an aqueous extract of Lepidi- um sativum L. seeds on human breast cancer cells. Indian Journal of Tradi- tional Knowledge 2013; 12: 605-614.
• Sokmen A, Jones BM, Erturk M. The in vitro antibacterial activity of Turkish plants. J Ethnopharmacol 1999; 67: 79- 86.
• Ozturk N, Tuncel M & Tuncel NB. Determination of phenolic acids by a modified HPLC: Its application to vari- ous plant materials. J Liq Chromatogr Relat Technol 2007; 30: 587-96.
• Russo A, Acquaviva R, Campisi A, Sorrenti V, Di Giacomo C, Virgata G, Barcellona ML, Vanella A. Bioflavo- noids as antiradicals, antioxidants and DNA cleavage protectors. Cell Biol Toxicol 2000; 16: 91-8.
• Jost LM, Kirkwood JM, Whiteside TL. Improved short- and long term XTT- based colorimetric cellular cytotoxicity assay for melanoma and other tumor cells. J immunol methods 1992; 147: 153-65.
• Bürgermeister J, Paper DH, Vogl H, Linhardt RJ, Franz G. LAPSvS1, a (1- - >3) - beta galactan sulfate and its effect on angiogenesis in vitro and in vivo. CarbohydrRes 2002; 337: 1459-66.
• Demirci B, Dadandi MY, Paper DH, Franz G, Başer KH. Chemical composi- tion of the essential oil of Phlomis line- aris Boiss & Bal., and biological effects on CAM assay: a safety evaluation. Z. Naturforsch C 2003; 58: 826-29.
• Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropa- thol 2007; 114: 97-109.
• Omuro A, De Angelis LM. Glioblas- toma and other malignant gliomas: a clinical review. JAMA 2013; 310: 1842-50.
• Chaichana KL, Zadnik P, Weingart JD, Olivi A, Gallia GL, Blakeley J, Lim M, Brem H, Quiñones-Hinojosa A. Multi- ple resections for patients with glioblas- toma: prolonging survival. J Neurosurg 2013; 118: 812-20.
• Kroeger KM, Muhammad AK, Baker GJ, Assi H, Wibowo MK, Xiong W, Yagiz K, Candolfi M, Lowenstein PR, Castro MG. Gene therapy and virother- apy: novel therapeutic approaches for brain tumors. Discov Med 2010; 10: 293-304.
• Guo Y, Wang G, Gao WW, Cheng SW, Wang R, Ju SM, Cao HL, Tian HL. In- duction of apoptosis in glioma cells and up regulation of Fas expression using the human interferon-? gene. Asian Pac J Cancer Prev 2012; 13: 2837-40.
• Chou TH, Ding HY, Hung WJ, Liang CH. Antioxidative characteristics and inhibition of
• alpha-melanocyte- stimulating hormone-stimulated mela- nogenesis of vanillin and vanillic acid from Origanum vulgare. Exp Dermatol 2010; 19: 742-50.
• Stanely Mainzen Prince P, Rajakumar S, Dhanasekar K. Protective effects of vanillic acid on electrocardiogram, lipid peroxidation, antioxidants, proinflam- matory markers and histopathology in isoproterenol induced cardiotoxic rats. Eur J Pharmacol 2011; 668: 233-40.
• Kumar S, Prahalathan P, Raja B. An- tihypertensive and antioxidant potential of vanillic acid, a phenolic compound in L-NAME-induced hypertensive rats: a dose-dependence study. Redox Rep 2011; 16: 208-15.
• Kim MC, Kim SJ, Kim DS, Jeon YD, Park SJ, Lee HS, Um JY, Hong SH. Vanillic acid inhibits inflammatory me- diators by suppressing NF-?B in lipo- polysaccharide-stimulated mouse peri- toneal macrophages. Immunopharmacol Immunotoxicol 2011; 33: 525-32.
• Tsuda H, Uehara N, Iwahori Y, Asamo- to M, Iigo M, Nagao M, Matsumoto K, Ito M, Hirono I. Chemopreventive ef- fects of beta-carotene, alpha-tocopherol and five naturally occurring antioxi- dants on initiation of hepatocarcinoge- nesis by 2-amino-3-methylimidazo[4,5- f]quinoline in the rat. Jpn J Cancer Res 1994; 85: 1214-9.
• Durant S, Karran P. Vanillins--a novel family of DNA-PK inhibitors. Nucleic Acids Res 2003; 31: 5501-12.
• Karunanidhi A, Thomas R, van Belkum A, Neela V. In vitro antibacterial and antibiofilm activities of chlorogenic ac- id against clinical isolates of Stenotrop- homonas maltophilia including the tri- metoprim/sulfamethoxazole train, Biomed Res Int 2013; 392058.
• Mekhora C, Muangnoi C, Ching- suwanrote P, Dawilai S, Svasti S, Chasri K, Tuntipopipat S. Eryngium foetidum suppresses inflammatory me- diators produced by macrophages. Asian Pac J Cancer Prev 2012; 13: 653- 64.
• Hwang SJ, Kim YW, Park Y, Lee HJ, Kim KW. Anti-inflammatory effects of chlorogenic acid in lipopolysaccharide- stimulated RAW 264.7cells. Inflamm Res 2014; 63: 81-90.
• Suzuki A, Yamamoto N, Jokura H, Yamamoto M, Fujii A, Tokimitsu I, Saito I. Chlorogenic acid attenuates hy- pertension and improves endothelial function in spontaneously hypertensive rats, J Hypertens 2006; 24: 1065-73. 43.
• Kanno Y, Watanabe R, Zempo H, Ogawa M, Suzuki J, Isobe M. Chlorogenic acid attenuates ventricular remodeling after myocardial infarction in mice. Int Heart J 2013; 54: 176-80.
• Wan CW, Wong CN, Pin WK, Wong MH, Kwok CY, Chan RY, Yu PH, Chan SW. Chlorogenic acid exhibits cholesterol lowering and fatty liver at- tenuating properties by up-regulating the gene expression of PPAR-? in hy- percholesterolemic rats induced with a high-cholesterol diet. Phytother Res 2013; 27: 545-51.
• RakshitS, Mandal L, Pal BC, Bagchi J, Biswas N, Chaudhuri J, Chowdhury AA, Manna A, Chaudhuri U, Konar A, Mukherjee T, Jaisankar P, Bandyo- padhyay S. Involvement of ROS in chlorogenic acid-induced apoptosis of Bcr-Abl+ CML cells. Biochem Phar- macol 2010; 80: 1662-75.
• Ooi KL, Muhammad TS, Tan ML, Sulaiman SF. Cytotoxic, apoptotic and anti-?-glucosidase activities of 3,4-di- O-caffeoyl quinic acid, an antioxidant isolated from the polyphenolic-rich ex- tract of Elephantopus mollis Kunth. J Ethno pharmacol 2011; 135: 685-95.
• Belkaid A, Currie JC, Desgagnés J, Annabi B. The chemopreventive prop- erties of chlorogenic acid reveal a po- tential new role for the microsomal glu- cose-6-phosphate translocase in brain tumor progression. Cancer Cell Int 2006; 6: 7.
• Arrillaga-Romany I, Reardon DA, Wen PY. Current status of antiangiogenic therapies for glioblastomas. Expert Opin Investig Drugs 2014; 23: 199-210.
• Zhu LM, Zhao YZ, Ju HX, Liu LY, Chen L, Liu BX, Xu Q, Luo C, Ying JE, Yang YS, Zhong HJ. Efficacy and safety of bevacizumab in Chinese pa- tients with metastatic colorectal cancer. Asian Pac J Cancer Prev 2014; 15: 6559-64.
• WickW, Cloughesy TF, Nishikawa R, Mason W, Saran F, Henricksson R, Hil- ton M, Kerloeguen Y, Chino OL. Tu- mor response based on adapted Mac- donald criteria and assessment of pseu- doprogression (PsPD) in the phase III AVAglio trial of bevacizumab (Bv) plus temozolomide (T) plus radiothera- py (RT) in newly diagnosed glioblas- toma (GBM). Journal of Clinical On- cology 2013; 31: 2002.
• Gilbert MR, Dignam JJ, Armstrong TS, Wefel JS, Blumenthal DT, Vogelbaum MA, Colman H, Chakravarti A, Pugh S, Won M, Jeraj R, Brown PD, Jaeckle KA, Schiff D, Stieber VW, Brachman DG, Werner-Wasik M, Tremont-Lukats IW, Sulman EP, Aldape KD, Curran WJ Jr, Mehta MP. A randomized trial of bevacizumab for newly diagnosed glioblastoma. N Engl J Med 2014; 370: 699-708.